506-38-7
506-38-7 結(jié)構(gòu)式
基本信息
二十五碳酸
PENTACOSANOIC ACID
N-PENTACOSANOIC ACID 95+%
PENTACOSANOIC ACID(SG)
物理化學(xué)性質(zhì)
知名試劑公司產(chǎn)品信息
Pentacosanoic Acid,>95.0%(GC)(506-38-7)
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2025/12/22 | HY-124422 | 二十五烷酸 Pentacosanoic acid | 506-38-7 | 50mg | 550元 |
| 2025/12/22 | HY-124422 | 二十五烷酸 Pentacosanoic acid | 506-38-7 | 10mM * 1mLin DMSO | 605元 |
| 2025/12/22 | HY-124422 | 二十五烷酸 Pentacosanoic acid | 506-38-7 | 100mg | 1050元 |
常見問題列表
|
Human Endogenous Metabolite
|
The degree of demyelination in adrenoleukodystrophy is related to the Pentacosanoic to Docosanoic acid ratios (C25:0/C22:0 and C26:0/C22:0). Mainly saturated fatty acids of the middle class components (C24:0, C25:0 and C26:0) are found in severely affected areas where the active process is complete. Because a region of high long chain fatty acid content, lacking histopathological change, is detected.
The area with myelin destruction with axonal preservation is generally most prominent in the frontal edge of the lesion. A bell-shaped distribution of very long chain fatty acids, esterified to cholesterol, are detectable, with the mid-point being formed by Pentacosanoic (C25 : 0) and Hexacosanoic (C26 : 0) acids.